HCWB · HCW Biologics Inc.

HCW Biologics Inc. convened a Special Meeting of Stockholders on April 27, 2026, but failed to reach the necessary quorum to conduct business. Consequently, the meeting was adjourned without any votes taking place. The two proposals originally scheduled for the Special Meeting, which pertain to warrants issued to Armistice Capital Master Fund Ltd., will be included in the agenda for the upcoming Annual Meeting of Stockholders. The Annual Meeting is scheduled to be held virtually on June 15, 2026, at 10:00 A.M. Eastern Time, with a record date of April 22, 2026. The specific proposals involve seeking stockholder approval for warrants to purchase up to 5,497,702 shares of Common Stock at an exercise price of $0.6055 per share. These warrants are associated with a $17.4 million investment from Armistice Capital intended to fund clinical development programs. The Company stated it is obligated to continue soliciting votes and seeking approval every 60 days until stockholder approval is obtained, incurring associated costs until that time.